Human medicines European public assessment report (EPAR): Nugalviq, govorestat, Status: Application withdrawn

Orphan designation: daratumumab Treatment of plasma-cell myeloma, 17/07/2013 Expired

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, Date of authorisation: 13/03/2001, Revision: 51, Status: Authorised

Human medicines European public assessment report (EPAR): Rotarix, rotavirus vaccine, live, Date of authorisation: 21/02/2006, Revision: 47, Status: Authorised

EMA/PE/0000232781

EMA/PE/0000232771

EMA/PE/0000232769

Human medicines European public assessment report (EPAR): Enflonsia, clesrovimab, Date of authorisation: 15/04/2026, Revision: 1, Status: Authorised

EMA/PE/0000232764

EMA/PE/0000232763